Clinical Trials on Innate Immune Cells in Canada
Total 5568 results
-
Ryerson UniversityThe Hershey CompanyCompletedFood Intake | SatietyCanada
-
Université de MontréalUnknownEnergy IntakeCanada
-
Mount Saint Vincent UniversityUniversity of Toronto; IWK Health CentreCompleted
-
ATGen Canada IncTerminatedProstatic Neoplasm | Immunity, InnateCanada
-
University of GuelphAgriculture and Agri-Food Canada; Saskatchewan Pulse Growers; Pulse CanadaCompletedFood Intake | Satiety | AppetiteCanada
-
ATGen Canada IncTerminatedColorectal Cancer | Immunity, InnateCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedFood Intake Regulation | Substrate OxidationCanada
-
Universite de MonctonNew Brunswick Innovation FoundationCompletedEating Behavior | Fruit and Vegetable IntakeCanada
-
Universite de MonctonCompletedEating Behavior | Fruit and Vegetable IntakeCanada
-
Ryerson UniversityCompletedCognitive Change | Nutrition | Satiety | Food Intake ControlCanada
-
Lawson Health Research InstituteHamilton Health Sciences Corporation; London Health Sciences CentreCompletedClear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial CellsCanada
-
Circassia LimitedAdiga Life Sciences, Inc.Completed
-
Circassia LimitedAdiga Life Sciences, Inc.Completed
-
McGill UniversityUnknownCutaneous T-Cell LymphomaCanada
-
University Health Network, TorontoRecruitingDLBCL - Diffuse Large B Cell LymphomaCanada
-
University Health Network, TorontoNot yet recruitingDiffuse Large B Cell Lymphoma (DLBCL)Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Adult Diffuse Large Cell LymphomaCanada
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Not yet recruitingLung Cancer | Surgery | Circulating Tumor CellCanada
-
Université de SherbrookeUnknownLymphoma, Large-CellCanada
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedDiffuse Large B-Cell LymphomaCanada
-
AHS Cancer Control AlbertaNot yet recruiting
-
AEterna ZentarisCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
FSD Pharma, Inc.TerminatedMast Cell Activation Syndrome | Mast Cell Activation Disorder IdiopathicCanada, United States
-
University Health Network, TorontoCelgene CorporationCompleted
-
CancerCare ManitobaThe Leukemia and Lymphoma SocietyTerminatedChronic Lymphocytic LeukemiaCanada
-
AHS Cancer Control AlbertaHoffmann-La RocheCompletedDiffuse Large B Cell LymphomaCanada
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
British Columbia Cancer AgencyCompleted
-
University Health Network, TorontoCelgeneTerminatedChronic Lymphocytic LeukaemiaCanada
-
Sarit AssoulineNovartis; Hoffmann-La Roche; Quebec Clinical Research Organization in CancerCompletedDiffuse Large B Cell LymphomaCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedMelanoma | Lymphoma | Lymphoma, Non-Hodgkin | Carcinoma, Basal CellCanada
-
Sunnybrook Health Sciences CentreNovartisUnknownLeukemia, Lymphocytic, Chronic, B-CellCanada
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
Jewish General HospitalNovartis PharmaceuticalsTerminatedChronic Lymphocytic LeukemiaCanada
-
British Columbia Cancer AgencyNot yet recruitingMultiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell LymphomaCanada
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)Completed
-
Columbia UniversityCompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaCanada, United States
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaCanada
-
AHS Cancer Control AlbertaBoehringer Ingelheim; Cross Cancer InstituteWithdrawnSmall Cell Lung Cancer | Platinum-sensitiveCanada
-
Stephen CoubanGenzyme, a Sanofi CompanyCompletedMalignant Lymphoma, Stem Cell TypeCanada
-
Alberta Health Services, CalgaryAlberta Cancer Foundation; University of VictoriaRecruitingLymphoma | Leukemia | Multiple Myeloma | Blood Cancer | Stem Cell Transplant Complications | Chimeric Antigen Receptor T-cell TherapyCanada
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Canadian Cancer Trials GroupAbbVie; Roche Pharma AG; Incyte CorporationRecruiting
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
AHS Cancer Control AlbertaTerminatedRenal Cell Carcinoma | Neuroendocrine TumoursCanada
-
British Columbia Cancer AgencyUniversity of British Columbia; University of Utah; Pathway Genomics; Boreal GenomicsCompleted